3
Views
0
CrossRef citations to date
0
Altmetric
Review

Radiotherapy of skin cancers

, &
Pages 173-181 | Published online: 10 Jan 2014

References

  • Molife R, Hancock BW. Adjuvant therapy of malignant melanoma. Crit. Rev. Oncol. Hematol.44(1), 81–102 (2002).
  • Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J. Clin.56, 106–130 (2006).
  • Greinert R. Skin cancer: new markers for better prevention. Pathobiology76, 64–81 (2009).
  • Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A. Cutaneous malignant melanoma. Mayo Clin. Proc.81(4), 500–507 (2006).
  • Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res.10(1), 81–92 (2000).
  • Dummer R, Hauschild A, Jost L; ESMO Guidelines Working Group. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol.19(Suppl. 2), 86–88 (2008).
  • O’Brien CJ, Petersen-Schaefer K, Stevens GN et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck19(7), 589–594 (1997).
  • Ballo MT, Bonnen MD, Garden AS et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer97(7), 1789–1796 (2003).
  • Strojan P, Janĉar B, Ĉemažar M, Perme MP, Hoĉevar M. Melanoma metastases to the neck nodes: role of adjuvant irradiation. Int. J. Radiat. Oncol. Biol. Phys. (2009) (Epub ahead of print).
  • Burmeister BH, Mark Smithers B, Burmeister E et al. A prospective Phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06. Radiother. Oncol.81(2), 136–142 (2006).
  • Temam S, Mamelle G, Marandas P et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer103(2), 313–319 (2005).
  • Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer110(8), 1791–1795 (2007).
  • Sloan AE, Nock CJ, Einstein DB. Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control16(3), 248–255 (2009).
  • Farshad A, Burg G, Panizzon R, Dummer R. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft x-rays. Br. J. Dermatol.146(6), 1042–1046 (2002).
  • Schmid-Wendtner MH, Brunner B, Konz B et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J. Am. Acad. Dermatol.43, 477–482 (2000).
  • Wada H, Nemoto K, Ogawa Y et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan. Int. J. Radiat. Oncol. Biol. Phys.59(2), 495–500 (2004).
  • Testori A, Rutkowski P, Marsden J et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann. Oncol.20(Suppl. 6), vi22–vi29 (2009).
  • de Vries E, de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br. J. Dermatol.152, 481–488 (2005).
  • Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer – the role of sunlight. Adv. Exp. Med. Biol.624, 89–103 (2008).
  • Oberyszyn TM. Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D. Cancer Lett.261(2), 127–136 (2008).
  • Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer8(10), 743–754 (2008).
  • Finizio L, Vidali C, Calacione R, Beorchia A, Trevisan G. What is the current role of radiation therapy in the treatment of skin carcinomas? Tumori88(1), 48–52 (2002).
  • Avril MF, Auperin A, Margulis A et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br. J. Cancer76(1), 100–106 (1997).
  • Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int. J. Radiat. Oncol. Biol. Phys.60, 406–411 (2004).
  • Veness MJ. The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J. Med. Imaging Radiat. Oncol.52, 278–286 (2008).
  • Liu FF, Maki E, Warde P, Payne D, Fitzpatrick P. A management approach to incompletely excised basal cell carcinomas of skin. Int. J. Radiat. Oncol. Biol. Phys.20(3), 423–428 (1991).
  • Breuninger H, Sebastian G, Kortmann RD, Schwipper V, Werner J, Garbe C. [German guideline: Basal cell carcinoma. In: Interdisciplinary guidelines for diagnostics and treatment of skin tumors]. Garbe C. Georg Thieme Verlag, Stuttgart, Germany, 1–11 (2005).
  • Veness MJ, Chong L, Tiver K, Gebski V. Basal cell carcinoma of the nose: an Australian and New Zealand Radiation Oncology patterns-of-practice study. J. Med. Imaging Radiat. Oncol.52, 382–393 (2008).
  • Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J. Am. Acad. Dermatol.26, 467–484 (1992).
  • Mullen JT, Feng L, Xing Y et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann. Surg. Oncol.13(7), 902–909 (2006).
  • Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin. The incidence of metastasis and their outcome. Aust. NZ J. Surg.62, 5 (1991).
  • Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br. J. Dermatol.146, 18–25 (2002).
  • Babington S, Veness MJ, Cakir B, Gebski VJ, Morgan GJ. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ J. Surg.73, 621–625 (2003).
  • Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck29, 621–631 (2007).
  • Mendenhall NP, Million RR, Cassisi NJ. Parotid area lymph node metastases from carcinoma of the skin. Int. J. Radiat. Oncol. Biol. Phys.11, 707–714 (1985).
  • Chen AM, Grekin RC, Garcia J, Bucci MK, Margolis LW. Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations. Int. J. Radiat. Oncol. Biol. Phys.69(5), 1377–1380 (2007).
  • Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer109(6), 1053–1059 (2007).
  • Rudolph R, Zelac DE. Squamous cell carcinoma of the skin. Plast. Reconstr. Surg.114(6), 82e–94e (2004)
  • Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol. Biomarkers Prev.8, 153–158 (1999).
  • Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J. Am. Acad. Dermatol.37(5 Pt 1), 734–739 (1997).
  • Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann. Surg. Oncol.8, 204–208 (2001).
  • Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch. Dermatol.142(6), 771–774 (2006).
  • Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of merkel cell carcinoma. Am. J. Clin. Oncol.27(5), 510–515 (2004).
  • Roeder F, Krempien R, Sterzing F et al. Radiotherapy for localized and advanced Merkel cell carcinoma of the skin: a single institution case series. Eur. J. Dermatol.17(3), 229–233 (2007).
  • Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of merkel cell carcinoma: case series and review of 1024 cases. Ann. Surg. Oncol.8, 204–208 (2001).
  • Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J. Am. Acad. Dermatol.57(1), 166–169 (2007).
  • Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J. Clin. Oncol.25, 1043–1047 (2007).
  • Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J. Clin. Oncol.23, 2300–2309 (2005).
  • Mortier L, Mirabel X, Fournier C, Piette F, Lartigau E. Radiotherapy alone for primary Merkel cell carcinoma. Arch. Dermatol.139, 1587–1590 (2003).
  • Becker G, Bottke D. Radiotherapy in the management of Kaposi’s sarcoma. Onkologie29(7), 329–333 (2006).
  • International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J. Natl Cancer Inst.92, 1823–1830 (2000).
  • Stein ME, Lakier R, Spencer D et al. Radiation therapy for non-AIDS associated (classic and endemic African) and epidemic Kaposi’s sarcoma. Int. J. Radiat. Oncol. Biol. Phys.28, 613–619 (1994).
  • Le Bourgeois JP, Frikha H, Piedbois P, Lé Pechout C, Martin L, Haddad E. Radiotherapy in the management of epidemic Kaposi’s sarcoma of the oral cavity, the eyelid and the genitals. Radiother. Oncol.30, 263–266 (1994).
  • Berson AM, Quivey JM, Harris JW et al. Radiation therapy for AIDS-related Kaposi’s sarcoma. Int. J. Radiat. Oncol. Biol. Phys.19, 569–575 (1990).
  • Stelzer KJ, Griffin TW. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi’s sarcoma. Int. J. Radiat. Oncol. Biol. Phys.27, 1057–1061 (1993).
  • Kirova Y, Belembaogo E, Frikha H et al. Radiotherapy in the management of epidemic Kaposi’s sarcoma: a retrospective study of 643 cases. Radiother. Oncol.46, 19–22 (1998).
  • Yildiz F, Genc M, Akyurek S et al. Radiotherapy in the management of Kaposi’s sarcoma: comparison of 8 Gy versus 6 Gy. J. Natl Med. Assoc.98(7), 1136–1139 (2006).
  • Syndikus I, Vinall A, Rogers P, Spittle M. High dose rate microselectron moulds for Kaposi sarcoma of the palate. Radiother. Oncol.42(2), 167–170 (1997).
  • Caccialanza M, Marca S, Piccinno R, Eulisse G. Radiotherapy of classic and human immunodeficiency virus-related Kaposi’s sarcoma: results in 1482 lesions. J. Eur. Acad. Dermatol. Venereol.22(3), 297–302 (2008).
  • Smith BD, Smith GL, Cooper DL, Wilson LD. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J. Clin. Oncol.23(15), 3390–3395 (2005).
  • Smith BD, Wilson LD. Cutaneous lymphoma. Semin. Radiat. Oncol.17(3), 158–168 (2007).
  • Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphoma. Blood105(10), 3768–3785 (2005).
  • Senff NJ, Hoefnagel JJ, Neelis KJ et al.; Dutch Cutaneous Lymphoma Group. Results of radiotherapy in 153 primary cutaneous B-cell lymphoma classified according to the WHO-EORTC classification. Arch. Dermatol.143(12), 1520–1526 (2007).
  • Smith BD, Glusac EJ, McNiff JM et al. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organisation for Research and Treatment of Cancer and the WHO classification systems. J. Clin. Oncol.22(4), 634–639 (2004).
  • Siegel RS, Pandolfino D, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphoma: review and current concepts. J. Clin. Oncol.18, 2908–2925 (2000).
  • Jones GW, Hoppe RT, Glatstein E. Electron beam treatment for cutaneous T-cell lymphoma. Hematol. Oncol. Clin. North Am.9, 1057–1076 (1995).
  • Jones GW, Rosenthal D, Wilson LD. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (Mycosis fungoides and the Sézary syndrome). Cancer85(9), 1985–1995 (1999).
  • Goujon E, Truc G, Pétrella T et al. Total skin electron beam therapy for early-stage mycosis fungoides: immediate results and long-term follow-up in 68 patients. Ann. Dermatol. Venereol.136(3), 249–255 (2009).
  • Funk A, Hensley F, Krempien R et al. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma. Eur. J. Dermatol.18(3), 308–312 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.